Fuji Pharma Co (FRA:FUP) OCF Margin %: 0.00% (As of Mar. 2026)


FRA:FUP Fuji Pharma Co Ltd FRA:FUP
84 GF Score
Price €11.60
GF Value €9.61
! 5 Warning Signs
View Full Analysis

What is Fuji Pharma Co OCF Margin %?

Fuji Pharma Co FRA:FUP -6.45% 84 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates FRA:FUP with a GF Score™ of 84/100 and a GF Value™ of €9.61. The stock has 5 warning signs investors should review. Among 959 Drug Manufacturers companies, Fuji Pharma Co ranks better than 50.68% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Fuji Pharma Co's Cash Flow from Operations for the three months ended in Mar. 2026 was €0.0 Mil. Fuji Pharma Co's Revenue for the three months ended in Mar. 2026 was €75.3 Mil. Therefore, Fuji Pharma Co's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Fuji Pharma Co's current OCF Yield % is 9.68%.

The historical rank and industry rank for Fuji Pharma Co's OCF Margin % or its related term are showing as below:

FRA:FUP' s OCF Margin % Range Over the Past 10 Years
Min: -1.86   Med: 10.59   Max: 19.39
Current: 10.3

During the past 13 years, the highest OCF Margin % of Fuji Pharma Co was 19.39%. The lowest was -1.86%. And the median was 10.59%.

FRA:FUP's OCF Margin % is ranked better than
50.68% of 959 companies
in the Drug Manufacturers industry
Industry Median: 9.94 vs FRA:FUP: 10.30

Fuji Pharma Co OCF Margin % Related Terms

Fuji Pharma Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for Fuji Pharma Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuji Pharma Co OCF Margin % Chart

Fuji Pharma Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.63 -1.86 4.69 9.00 11.23

Fuji Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:FUP vs ZTS: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fuji Pharma Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fuji Pharma Co OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuji Pharma Co's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Fuji Pharma Co's OCF Margin % falls into.


FRA:FUP
84GF Score
Fuji Pharma Co Ltd FRA:FUP
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuji Pharma Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Fuji Pharma Co's OCF Margin for the fiscal year that ended in Sep. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=33.426/297.768
=11.23 %

Fuji Pharma Co's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/75.329
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Fuji Pharma Co (FRA:FUP) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Fuji Pharma Co and its competitors. According to the industry distribution chart, Fuji Pharma Co ranks #473 out of 959 companies in the Drug Manufacturers industry, placing it in the top 49.3%.
Is Fuji Pharma Co's OCF Margin % too high?
Fuji Pharma Co's current OCF Margin % is 0.00%. Based on the distribution chart, Fuji Pharma Co ranks #473 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Fuji Pharma Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Fuji Pharma Co's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Fuji Pharma Co ranks #473 out of 959 companies for OCF Margin %. This puts Fuji Pharma Co in the upper half of its industry. The industry median OCF Margin % is 9.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Fuji Pharma Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fuji Pharma Co's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuji Pharma Co stock overvalued right now?
Fuji Pharma Co (FRA:FUP) has a current OCF Margin % of 0.00%. The stock's GF Value™ is €9.61, compared to a current price of €11.60 — trading 20.7% above its estimated fair value. The current OCF Margin % is 0.00%. Fuji Pharma Co's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Fuji Pharma Co (FRA:FUP), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuji Pharma Co (FRA:FUP) Overvalued in 2026?

Based on GuruFocus' analysis, Fuji Pharma Co stock appears to be overvalued. The current stock price of €11.60 is trading 20.7% above its estimated GF Value™ of €9.61.

Key valuation signals for FRA:FUP:

  • OCF Margin %: 0.00%
  • GF Value™: €9.61 vs. price of €11.60 (20.7% above fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the FRA:FUP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fuji Pharma Co Business Description

Other Exchanges 4554:Japan
Address 5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
84GF Score

Get the complete analysis for FRA:FUP

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.60
Price
€9.61
GF Value